Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Aditxt Inc
(NQ:
ADTX
)
2.100
+0.030 (+1.45%)
Streaming Delayed Price
Updated: 10:21 AM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Aditxt Inc
< Previous
1
2
3
4
5
6
Next >
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Issues Planned Strategy for Achieving Commercial Scale, Updated Release on 1-for-40 Reverse Split
August 18, 2023
Via
Investor Brand Network
Aditxt, Inc. (NASDAQ: ADTX) Provides Shareholder Update and Planned Strategy for Achieving Commercial Scale
August 18, 2023
From
Aditxt, Inc.
Via
Business Wire
CORRECTING and REPLACING Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-40 Reverse Stock Split Effective at the Open of Trading on August 18, 2023
August 17, 2023
From
Aditxt, Inc.
Via
Business Wire
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) to Effect 1-for-40 Reverse Stock Split
August 17, 2023
Via
Investor Brand Network
InvestorNewsBreaks – Aditxt Inc.’s (NASDAQ: ADTX) Pearsanta Inc. Enters LOI to Acquire Natural State Laboratories and Natural State Genomics
June 20, 2023
Via
Investor Brand Network
Aditxt, Inc.’s Wholly-Owned Subsidiary Pearsanta, Inc. Looks to Expand Customer Base, Payor Access, and Genetic Testing with a Non-Binding Letter of Intent to Acquire Natural State Laboratories and Natural State Genomics
June 20, 2023
From
Aditxt, Inc.
Via
Business Wire
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Subsidiary Inks Stiff Person Syndrome Clinical Trial Agreement with Mayo Clinic
May 05, 2023
Via
Investor Brand Network
Aditxt Subsidiary Adimune Signs Clinical Trial Agreement with Top Research Institution to Study Stiff Person Syndrome
May 05, 2023
From
Aditxt, Inc.
Via
Business Wire
Stem Cell Transplantation Shows Promise in Treating Autoimmune Disorders
May 03, 2023
Via
Investor Brand Network
Organ Donation, Transplantation: Challenges and How We Can Help More Individuals
April 27, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Closes on $1.9M Registered Direct Offering
April 25, 2023
Via
Investor Brand Network
Aditxt Announces Closing of $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
April 24, 2023
From
Aditxt,® Inc.
Via
Business Wire
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Registered Direct Offering Expected to Total $1.9M
April 21, 2023
Via
Investor Brand Network
InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Registered Direct Offering Expected to Total $1.9M
April 21, 2023
Via
Investor Brand Network
Aditxt Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
April 20, 2023
From
Aditxt, Inc.
Via
Business Wire
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Inks Asset Purchase Agreement for 50% Ownership of Global Response Aid
April 20, 2023
Via
Investor Brand Network
Aditxt Signs Asset Purchase Agreement to Acquire Fifty Percent Ownership of Global Response Aid – with Rights to Manufacture and Market Broad-Spectrum Antiviral Drug Avigan
April 20, 2023
From
Aditxt, Inc.
Via
Business Wire
Allergic Reactions Caused by Gel Nail Polishes on the Rise
April 19, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Releases Shareholder Update on Major Programs, M&A Plans
April 17, 2023
Via
Investor Brand Network
Exposures
COVID-19
Aditxt Issues Shareholder Update
April 17, 2023
From
Aditxt, Inc.
Via
Business Wire
US Federal Agency Plans to Overhaul Organ Transplant Network
April 13, 2023
Via
Investor Brand Network
Study Describes Link Between Viral infections, Autoimmune Diseases
April 06, 2023
Via
Investor Brand Network
Exposures
COVID-19
Study Suggests Giving Babies Peanut Butter Cuts Allergy Risk
March 31, 2023
Via
Investor Brand Network
Debate Rages Regarding Patients Listing on Multiple Organ Transplant Wait Lists
March 27, 2023
Via
Investor Brand Network
Researchers ID Substance That Could Make Autoimmune Disease Treatment Possible
March 21, 2023
Via
Investor Brand Network
How Research on Blood Cancer Could Benefit the Organ Transplant Field
March 15, 2023
Via
Investor Brand Network
FDA Issues Warning about Reliability of Food Allergy Skin Tests
March 08, 2023
Via
Investor Brand Network
Exposures
Product Safety
TinyGemsBreaks – Aditxt Inc. (NASDAQ: ADTX) Appoints Veteran of Media Industry as Chief Content, Engagement Officer
March 08, 2023
Via
Investor Brand Network
Aditxt Names Media Industry Veteran Maureen Connolly as Chief Content and Engagement Officer
March 08, 2023
From
Aditxt, Inc.
Via
Business Wire
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Retains Top Banking Firm to Support Growth, Revenue-Generating Strategy
March 03, 2023
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.